Extended Release Nifedipine Treatment as Maintenance Tocolysis to Prevent Preterm Delivery:A Prospective Interventional Study

The Baruch Padeh Medical Center, Poriya0 个研究点开始时间: 2007年12月最近更新: 2010年12月23日

适应症

干预措施

试验速览

阶段: 不适用
状态: 终止
发起方: The Baruch Padeh Medical Center, Poriya

研究概览研究设计入排标准研究组 & 干预措施研究者记录与标识符相似试验

研究概览

简要总结

To evaluate the treatment efficacy and safety usig extended release nifedipine, as maintenance therapy to pregnant women who were hospitalized and treated for preterm labor until 34 weeks' gestation. After the PTL will stop, we will randomize these women for the treatment group and the control (no treatment) group.

The main outcome will be preterm delivery before 34 weeks' gestation. the secondary outcome will be the side effects of the medication and the newborn/mother health variables.

研究设计

研究类型: Interventional
分配方式: Randomized
干预模型: Parallel
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 45 Years（Adult）
性别: Female
接受健康志愿者: 是

入选标准

•pregnancy week 24-33
•Singleton pregnancy
•After successful treatment to stop PTL

排除标准

•Contraindications for Nifedipine extended release treatment.

研究组 & 干预措施

A

Experimental

The treated group of pregnant women, after having successful treatment for PTL

干预措施: Nifedipine extended release (Drug)

研究者

发起方

The Baruch Padeh Medical Center, Poriya

申办方类型

Other Gov

相似试验

已完成

2 期

Tocolytic Therapy in Conservative Management of Symptomatic Placenta PreviaPlacenta Previa

NCT00620724University Hospital, Rouen109

终止

1 期

Maintenance Fedratinib to Prevent Post-Transplant Relapse in Myeloproliferative NeoplasmsMyeloproliferative Neoplasm

NCT05127174H. Lee Moffitt Cancer Center and Research Institute12

已完成

3 期

A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)Lung Diseases, Interstitial

NCT03820726Boehringer Ingelheim435

已完成

3 期

Switching Nevirapine Immediate Release( IR) Based Regimen to Nevirapine Extended Release (XR) Based Regimen in Human Immunodeficiency Virus One (HIV-1) Infected PatientsHIV Infections

NCT00819052Boehringer Ingelheim445

已完成

3 期

A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung FibrosisLung Diseases, Interstitial

NCT03313180Boehringer Ingelheim444